PhaseBio Pharmaceuticals Inc

PHASStocksPharmaceuticals MajorUnited StatesNasdaqUSD

Price

$3.65

Today

+0.0%

YTD

+0.0%

About

PhaseBio is an American healthcare firm with headquarters in Malvern, Pennsylvania. Founded in 2002, the company serves clients across the US, focusing on the development of new treatment options for serious cardiovascular diseases. Listed under the ticker PHAS, PhaseBio trades on the NASDAQ GM. Track this instrument via your eToro watchlist to get updates on PHAS price changes.

Price chart

Closing price history for PHAS (1D candles).

Open positions

Current open positions for this instrument from your live portfolio.

Open positions

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)0.00

P/S (TTM)0.01

P/B (TTM)-0.00

Market cap$0.00

Cap tierMicro-cap

Industry avg P/E-43.36

Profitability

Gross margin70.60%

EBIT margin-12738.63%

Net margin-8012.02%

ROE-3091.02%

ROA-167.49%

Earnings & Revenue

Revenue (TTM)$818,000.00

Revenue growth (1Y)-92.1%

EPS (TTM)-$2.13

Free cash flow$-61.82M

Total debt$5.37M

Dividends & Risk

Dividend rate$0.00

Dividend yield0.00%

Beta (5Y)-7.21

Employees60

Next earnings9 Nov '22

Trade history

Closed trades

Realized return

+0.0%

No stored closed trades exist for this instrument yet.